Showing results (131-140 of 181) with videos related to

Sort By:
Pageof 19
Cancer Chemotherapy and Pharmacology|October 8, 2008
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancerLorenzo Fornaro, G Masi, S Bursi, et al.
British Journal of Cancer|May 25, 2013
Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumabF Loupakis, M Schirripa, C Caparello, et al.
Mutation Research|September 16, 2003
Evaluation of the genotoxicity induced by the fungicide fenarimol in mammalian and plant cells by use of the single-cell gel electrophoresis assayP Poli, M A de Mello, A Buschini, et al.
Oncology|October 29, 2000
Oral doxifluridine in advanced hepatocellular carcinoma: A phase II studyM Lencioni, A Falcone, G Allegrini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
First-line 5-fluorouracil/folinic acid, oxaliplatin and irinotecan (FOLFOXIRI) does not impair the feasibility and the activity of second line treatments in metastatic colorectal cancerG Masi, L Marcucci, F Loupakis, et al.
British Journal of Cancer|March 17, 2011
Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancerF Loupakis, C Cremolini, A Fioravanti, et al.
British Journal of Cancer|March 26, 2008
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patientsG Allegrini, A Falcone, A Fioravanti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2011
An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patientsF Crea, L Fornaro, E Paolicchi, et al.
Journal of Mass Spectrometry : JMS|January 21, 2026
A Comprehensive Study of Anthocyanins in Two Fungal-Resistant Grape Varieties, Blueberry and Raspberry, by High-Resolution Mass SpectrometryM De Rosso, K Muniyandi, K Kumar, et al.
British Journal of Cancer|May 14, 2009
A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancerE Vasile, G Masi, L Fornaro, et al.
Pageof 19